Golden State Wealth Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1776033 SANTA ANA, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$161,336

-$7,998 QoQ

Shares Held

1,277

+5.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,943

of 2,266 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Golden State Wealth Management, LLC holds $5,982,098 across 14 Drug Manufacturers - General names. GILD ranks #9 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,159	$1,390,139
2	JNJ	Johnson & Johnson	4,761	$1,209,151
3	MRK	Merck & Co., Inc.	6,790	$872,515
4	ABBV	AbbVie Inc.	2,747	$691,255
5	AMGN	Amgen Inc	1,814	$656,885
6	PFE	Pfizer Inc	11,293	$271,935
7	AZN	Astrazeneca PLC	1,109	$210,288
8	BMY	Bristol Myers Squibb Co	3,040	$175,164

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$161,336	1,277	+5.1%	Shares	Sole	2026-07-22
2026-03-31	$169,334	1,215	+1.6%	Shares	Sole	2026-04-28
2025-12-31	$146,797	1,196	-3.2%	Shares	Sole	2026-02-13
2025-09-30	$137,085	1,235	+0.1%	Shares	Sole	2025-11-03
2025-06-30	$136,813	1,234	+43.0%	Shares	Sole	2025-08-06
2025-03-31	$96,699	863	+14.5%	Shares	Sole	2025-04-24
2024-12-31	$69,646	754	-78.2%	Shares	Sole	2025-01-28
2021-03-31	$223,749	3,462	-20.3%	Shares	Sole	2021-05-14
2020-12-31	$253,081	4,344	+620.4%	Shares	Sole	2021-01-28
2020-03-31	$45,080	603	—	Shares	Sole	2020-04-17
No filing history on record for this holder in this stock.